Neuroprotective mechanisms of sodium butyrate in Parkinson’s disease in preclinical rodent models: a systematic review and meta-analysis
Naunyn-Schmiedeberg's Archives of Pharmacology · 2026-02 · 399 (4) · 4707-4735
DOI: 10.1007/s00210-025-04740-5 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 25.10.2025. Verfasst von Leila Hosseini und 3 weiteren Autor:innen. Beteiligte Einrichtung: Research Center for Evidence-Based Medicine, Tabriz University of Medical Sciences, Tabriz, Iran. Hauptthemen laut MEDLINE: Butyric Acid, Neuroprotective Agents, Parkinson Disease. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 60 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Center for Evidence-Based Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
- Research Center of Psychiatry and Behavioral Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.
- Physical Medicine and Rehabilitation Research Centre, Tabriz University of Medical Sciences, Tabriz, Iran.
- Traditional Medicine and Hydrotherapy Research Center, Ardabil University of Medical Sciences, Ardabil, Iran.
- Traditional Medicine and Hydrotherapy Research Center, Ardabil University of Medical Sciences, Ardabil, Iran. l.maghsumi55@gmail.com.
- Department of Clinical Nutrition, Faculty of Nutrition and Food Sciences, Tabriz University of Medical Sciences, Tabriz, Iran. l.maghsumi55@gmail.com.
Zitieren
APA
Hosseini, L., Farshbaf-Khalili, A., Jazani, A. M., & Maghsoumi-Norouzabad, L. (2026). Neuroprotective mechanisms of sodium butyrate in Parkinson’s disease in preclinical rodent models: a systematic review and meta-analysis. Naunyn-Schmiedeberg's Archives of Pharmacology, 399(4), 4707-4735. https://doi.org/10.1007/s00210-025-04740-5
Vancouver
Hosseini L, Farshbaf-Khalili A, Jazani AM, Maghsoumi-Norouzabad L. Neuroprotective mechanisms of sodium butyrate in Parkinson’s disease in preclinical rodent models: a systematic review and meta-analysis. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026;399(4):4707-4735. doi:10.1007/s00210-025-04740-5
BibTeX
@article{Hosseini2026,
author = {Hosseini, Leila and Farshbaf-Khalili, Azizeh and Jazani, Arezoo Moini and Maghsoumi-Norouzabad, Leila},
title = {Neuroprotective mechanisms of sodium butyrate in Parkinson’s disease in preclinical rodent models: a systematic review and meta-analysis},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2026},
volume = {399},
number = {4},
pages = {4707--4735},
doi = {10.1007/s00210-025-04740-5}
}
EUVIMED